Current Value of Holding

$608 Million

Shares

5.06 Million

% of Portfolio

0.45%

Average Buy Price

$120

Avg closing price
Price range

45 PRIMECAP Management Zimmer Biomet Holdings Trades

PRIMECAP Management's position in Zimmer Biomet Holdings is currently worth $608 Million. That's 0.45% of their equity portfolio (53rd largest holding). The investor owns 2.44% of the outstanding Zimmer Biomet Holdings stock. The first Zimmer Biomet Holdings trade was made in Q1 2013. Since then PRIMECAP Management bought shares 22 more times and sold shares on 22 occasions. The investor's estimated purchase price is $610 Million, resulting in a loss of 0.2%.

Avg closing price
Price range
Sold 0.5% shares (-23.6 Thousand shares) Q1 2024
Avg closing price $124.91
Price range $119.98 - $132.61
Increased shares by 10.5% (+484 Thousand shares) Q4 2023
Avg closing price $111.58
Price range $102.72 - $121.70
Sold 5.4% shares (-260 Thousand shares) Q3 2023
Avg closing price $126.99
Price range $110.76 - $143.18
Sold 1.5% shares (-72.1 Thousand shares) Q2 2023
Avg closing price $135.90
Price range $126.43 - $145.60
Increased shares by 2.1% (+104 Thousand shares) Q1 2023
Avg closing price $125.55
Price range $121.91 - $130.94
Sold 1.6% shares (-76.4 Thousand shares) Q4 2022
Avg closing price $116.05
Price range $104.85 - $128.43
Sold 0.0% shares (-775 shares) Q3 2022
Avg closing price $109.74
Price range $101.65 - $119.27
Sold 0.5% shares (-23.1 Thousand shares) Q2 2022
Avg closing price $118.64
Price range $102.23 - $133.85
Increased shares by 21.2% (+863 Thousand shares) Q1 2022
Avg closing price $122.78
Price range $111.67 - $130.44
Increased shares by 4.9% (+191 Thousand shares) Q4 2021
Avg closing price $134.80
Price range $118.89 - $151.03
Increased shares by 7.7% (+277 Thousand shares) Q3 2021
Avg closing price $151.51
Price range $140.44 - $163.52
Increased shares by 2.6% (+92.7 Thousand shares) Q2 2021
Avg closing price $166.84
Price range $157.54 - $178.61
Increased shares by 0.7% (+24.6 Thousand shares) Q1 2021
Avg closing price $159.55
Price range $152.60 - $164.50
Sold 5.0% shares (-185 Thousand shares) Q4 2020
Avg closing price $145.47
Price range $132.10 - $155.95
Increased shares by 1.7% (+62.8 Thousand shares) Q3 2020
Avg closing price $134.55
Price range $117.00 - $145.93
Increased shares by 5.4% (+183 Thousand shares) Q2 2020
Avg closing price $118.69
Price range $89.63 - $137.40
Increased shares by 16.7% (+489 Thousand shares) Q1 2020
Avg closing price $135.02
Price range $80.63 - $160.40
Sold 0.3% shares (-8.2 Thousand shares) Q4 2019
Avg closing price $142.18
Price range $131.22 - $151.24
Increased shares by 15.2% (+387 Thousand shares) Q3 2019
Avg closing price $133.05
Price range $116.73 - $142.61
Increased shares by 3.7% (+90.4 Thousand shares) Q2 2019
Avg closing price $120.64
Price range $112.14 - $128.84

News about Zimmer Biomet Holdings Inc and PRIMECAP Management

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!